Modification of the glyoxalase system in disease processes and prospects for therapeutic strategies.
Thornalley
P J
PJ
Department of Chemistry and Biological Chemistry, University of Essex, Colchester, U.K.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000201:enzymology; D006801:Humans; D007791:Lactoylglutathione Lyase / Q000187:drug effects*; D009369:Neoplasms / Q000201:enzymology; D013869:Thiolester Hydrolases / Q000187:drug effects*; D000099301:Hydroxyacylglutathione Hydrolase
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D007791:Lactoylglutathione Lyase; D013869:Thiolester Hydrolases; D000099301:Hydroxyacylglutathione Hydrolase